These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6724258)

  • 21. Increased sulfation of lithocholate in patients with cholesterol gallstones during chenodeoxycholate treatment.
    Stiehl A; Raedsch R; Kommerell B
    Digestion; 1975; 12(2):105-10. PubMed ID: 1158064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of hydrophobic and hydrophilic bile salts on gallstone growth and dissolution in model biles.
    Venneman NG; van Kammen M; Renooij W; Vanberge-Henegouwen GP; van Erpecum KJ
    Biochim Biophys Acta; 2005 Jan; 1686(3):209-19. PubMed ID: 15629690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural alterations in lecithin-cholesterol vesicles following interactions with monomeric and micellar bile salts: physical-chemical basis for subselection of biliary lecithin species and aggregative states of biliary lipids during bile formation.
    Cohen DE; Angelico M; Carey MC
    J Lipid Res; 1990 Jan; 31(1):55-70. PubMed ID: 2313205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined bile acid therapy is more effective on biliary lipids and dissolution rates than monotherapy after gallstone lithotripsy.
    Tudyka J; Kratzer W; Janowitz P; Mason R; Wechsler JG
    Am J Gastroenterol; 1995 Nov; 90(11):1942-8. PubMed ID: 7484996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Solubilization and precipitation of biliary cholesterol. Mechanisms of dissolution of cholesterol calculi].
    Montet JC; Lindheimer M
    Gastroenterol Clin Biol; 1984 Jan; 8(1):62-9. PubMed ID: 6365676
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of the purified unsaponifiable fraction of soybean in combination with ursodeoxycholic acid on cholesterol saturation of bile and stone dissolution in gallstone patients.
    Kajiyama G; Kawamoto T; Fujiyama M; Maruhashi A; Miyoshi A
    Hiroshima J Med Sci; 1981 Jun; 30(2):71-83. PubMed ID: 7028684
    [No Abstract]   [Full Text] [Related]  

  • 27. pH-Solubility relations of chenodeoxycholic and ursodeoxycholic acids: physical-chemical basis for dissimilar solution and membrane phenomena.
    Igimi H; Carey MC
    J Lipid Res; 1980 Jan; 21(1):72-90. PubMed ID: 7354256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol carriers in human bile: are "lamellae" involved?
    Cohen DE; Kaler EW; Carey MC
    Hepatology; 1993 Dec; 18(6):1522-31. PubMed ID: 8244279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatotoxicity of bile acids in rabbits: ursodeoxycholic acid is less toxic than chenodeoxycholic acid.
    Miyai K; Javitt NB; Gochman N; Jones HM; Baker D
    Lab Invest; 1982 Apr; 46(4):428-37. PubMed ID: 7200166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gallstones: current concepts of pathogenesis and medical dissolution.
    Shaffer EA
    Can J Surg; 1980 Nov; 23(6):517-32, 557. PubMed ID: 7004612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of biliary microscopy for the prediction of the chemical composition of gallstones and the outcome of dissolution therapy with ursodeoxycholic acid.
    Ros E; Navarro S; Fernández I; Reixach M; Ribó JM; Rodés J
    Gastroenterology; 1986 Sep; 91(3):703-12. PubMed ID: 3732768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addition of N-acetylcysteine to aqueous model bile systems accelerates dissolution of cholesterol gallstones.
    Niu N; Smith BF
    Gastroenterology; 1990 Feb; 98(2):454-63. PubMed ID: 2295402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The "mirroring" of gallstones: description of a novel silvering method to determine the surface area of an irregular object. In vitro demonstration that multiple gallstones from the same gallbladder dissolve in unsaturated "bile" at the same rate.
    Park YH; Igimi H; Carey MC
    Gastroenterology; 1982 Nov; 83(5):1071-8. PubMed ID: 7117790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ursodeoxycholic acid in the treatment of gallbladder lithiasis].
    Mamianetti A; Labonia NA; Lafont D; Fiordalisi HH
    Acta Gastroenterol Latinoam; 1982; 12(1):33-8. PubMed ID: 7136453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unusual trihydroxy bile acids in the urine of patients treated with chenodeoxycholate, ursodeoxycholate or rifampicin and those with cirrhosis.
    Nakashima T; Sano A; Seto Y; Nakajima T; Shima T; Sakamoto Y; Okuno T; Kashima K; Hasegawa T
    Hepatology; 1990 Feb; 11(2):255-60. PubMed ID: 2307404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavior of various cholesterol crystals in bile from patients with gallstones.
    Portincasa P; van Erpecum KJ; Jansen A; Renooij W; Gadellaa M; vanBerge-Henegouwen GP
    Hepatology; 1996 Apr; 23(4):738-48. PubMed ID: 8666327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesophase formation during cholesterol dissolution in ursodeoxycholate-lecithin solutions: new mechanism for gallstone dissolution in humans.
    Corrigan OI; Su CC; Higuchi WI; Hofmann AF
    J Pharm Sci; 1980 Jul; 69(7):869-71. PubMed ID: 7391960
    [No Abstract]   [Full Text] [Related]  

  • 39. Ursodeoxycholate stabilizes phospholipid-rich membranes and mimics the effect of cholesterol: investigations on large unilamellar vesicles.
    Güldütuna S; Deisinger B; Weiss A; Freisleben HJ; Zimmer G; Sipos P; Leuschner U
    Biochim Biophys Acta; 1997 Jun; 1326(2):265-74. PubMed ID: 9218557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholesterol (thermodynamic) activity determinations in bile salt-lecithin-cholesterol systems and cholesterol-rich liquid crystalline mesophase formation.
    Jain UK; Higuchi WI; Liu CL; Lee PH; Mazer NA
    Pharm Res; 1992 Jun; 9(6):792-9. PubMed ID: 1409363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.